April 2018 Investment Performance

April 2018 Investment Performance

Capital markets continued to gyrate in April. We used the correction to add new positions and correspondingly reduced our cash weighting. An overview of the performance of our actively-managed products is as follows:

  • The AFINA Optima10 was down 1.1% in April. The Optima10 is now fully invested with a 5% cash weighting and a 3.64% dividend yield. Consumer/health care stocks accounted for a 38.0% weighting, financials represented 47.5% and technology was 9.5%.
  • The AFINA Affinity was down 0.9% in April. The Affinity now has a 18.0% cash weighting and a 2.74% dividend yield. Consumer/health care stocks accounted for a 35.0% weighting, financials represented 34.0% and technology was 10.0%.

 

As of April 30, 2018. All figures are net of fees and other expenses. Past performance is not indicative of future results. Refer to https://www.afinacapital.com/legal/ for full details and disclosures.
(1) The benchmark represents a 50% weighting of the S&P 500 Total Return Index in Canadian dollars and a 50% weighting of the S&P/TSX Composite Total Return Index in Canadian dollars.